U.S. Communications Stock News

NasdaqCM:SAVA
NasdaqCM:SAVAPharmaceuticals

What Does Cassava Sciences (SAVA) CEO’s Insider Buy Reveal About Its Post-Alzheimer’s Strategy?

Earlier this month, Cassava Sciences President and CEO Richard Barry made a significant personal investment by acquiring 237,941 shares valued at US$534,743 following the discontinuation of the company’s Alzheimer’s drug program due to disappointing clinical trial results. This marked Barry’s first insider purchase in over a year and is being interpreted as a sign of confidence in Cassava’s remaining pipeline and future direction, as the company focuses on new opportunities including a...
NasdaqCM:MLGO
NasdaqCM:MLGOIT

MicroAlgo (MLGO): Evaluating Valuation After S&P Global BMI Index Inclusion

MicroAlgo (NasdaqCM:MLGO) just scored a highly visible milestone by being added to the S&P Global BMI Index. If you have been following the company, you already know that this sort of index inclusion can bring in fresh attention from institutional investors and fund managers. For those on the fence about the stock, the big question now is whether this event is a game-changer or just another headline in a volatile year. This development comes after a string of mixed returns for MicroAlgo, with...
NasdaqGS:PEPG
NasdaqGS:PEPGBiotechs

PepGen (PEPG): Assessing Valuation Following Encouraging FREEDOM-DM1 Phase 1 Clinical Update

If you’ve been following PepGen (PEPG), the latest clinical update might have you rethinking your next move. The company just released results from the 15 mg/kg cohort of its FREEDOM-DM1 Phase 1 study for myotonic dystrophy type 1, showing progress for its investigational candidate, PGN-EDODM1. With plans to expand its trials in the coming quarters, PepGen is clearly pushing its development pipeline forward. News like this often attracts investor attention when positive data is...
NasdaqCM:RCT
NasdaqCM:RCTRetail Distributors

Could RedCloud Holdings' (RCT) NVIDIA Partnership Reveal Its Next Move in Global Supply Chain Innovation?

On September 24, 2025, RedCloud Holdings plc announced it has joined the NVIDIA Connect program, enabling its development teams to access NVIDIA's advanced AI frameworks and resources to accelerate innovation in global trade solutions. This initiative reinforces RedCloud’s commitment to leveraging cutting-edge technology to tackle the $2 trillion global inventory gap impacting the $14.6 trillion global FMCG industry. We'll explore how RedCloud’s adoption of NVIDIA’s AI capabilities could...
NYSE:OBDC
NYSE:OBDCCapital Markets

Blue Owl Capital (OBDC): Valuation Insights as Leadership Prioritizes AI Initiatives After Annual Summit

Blue Owl Capital (OBDC) made waves this week as company leadership took the spotlight at the 3rd Annual AI Summit, placing a bold emphasis on artificial intelligence initiatives. This isn’t just a casual mention; Blue Owl is actively signaling to investors and the industry that it plans to address technological disruption head-on. The focus on AI, delivered by Principal and Chief of Staff Jared Sheiker at the summit, suggests a pivot toward strategies that could redefine its future growth and...
NasdaqGM:CDLX
NasdaqGM:CDLXMedia

Cardlytics (CDLX) Is Up 16.0% After Citron Flags Major Partnership Potential – What's Changed

Earlier this week, Cardlytics saw increased public attention after Citron Research released a report highlighting the company's potential upside if it secures a major customer for its rewards platform. This analysis by Citron points to the potential for Cardlytics to transform its business model and broaden consumer benefits if a significant publisher partnership materializes. We'll review what Citron Research's focus on a possible major customer announcement might mean for Cardlytics'...